During the past decade, Florida Cancer Specialists conducted 63 clinical trials. In the 10-year time frame, 63 clinical trials started and 53 clinical trials were completed, i.e. on average, 84.1% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 32 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Florida Cancer Specialists" #1 sponsor was "Hoffmann-La Roche" with 14 trials, followed by "Eli Lilly and Company" with 12 trials sponsored, "Bristol-Myers Squibb" with 9 trials sponsored, "Pfizer" with 8 trials sponsored and "Genentech, Inc." with 8 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 30 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Florida Cancer Specialists" #1 collaborator was "Eli Lilly and Company" with 4 trials as a collaborator, "Astellas Pharma Inc" with 3 trials as a collaborator, "Ono Pharmaceutical Co. Ltd" with 3 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator and "Medivation, Inc." with 2 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Florida Cancer Specialists" are "Breast Cancer" (10 trials), "Non-Small Cell Lung Cancer" (7 trials), "Metastatic Breast Cancer" (6 trials), "Carcinoma, Non-Small-Cell Lung" (5 trials) and "Breast Neoplasms" (4 trials). Many other conditions were trialed in "Florida Cancer Specialists" in a lesser frequency.

Most popular intervention types in "Florida Cancer Specialists" are "Drug" (82 trials), "Biological" (8 trials), "Other" (8 trials), "Procedure" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Carboplatin" (8 trials), "Nivolumab" (8 trials), "Abemaciclib" (7 trials) and "Docetaxel" (7 trials). Other intervention names were less common.

The vast majority of trials in "Florida Cancer Specialists" are 76 trials for "All" genders, 11 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Florida Cancer Specialists". undefined are not yet recruiting, 14 are recruiting, 22 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 40 completed trials in Florida Cancer Specialists, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Florida Cancer Specialists, 5 "Phase 1" clinical trials were conducted, 41 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".